Clarion Solicitors selects Ascertus for move to the iManage Cloud

Leeds-based law firm, Clarion Solicitors, has chosen Ascertus Limited as its implementation partner to migrate the firm from its on-premises version of iManage Work document management system to the iManage Cloud. Ascertus will deliver the iManage Cloud to over 230 users in the firm’s Leeds office, migrating nearly 6.5 million documents. A statement from Ascertus said: “This move will deliver IT cost savings to Clarion, whilst ensuring the highest levels of data security for the information residing in the document management system.” Ascertus provides document and information lifecycle management solutions to law firms and corporate legal departments in the UK and across Europe.
Dan Mitchell, head of IT at Clarion Solicitors said, “Ascertus is iManage Cloud Partner of the Year, which speaks volumes of the organisation’s capabilities. On meeting with the team, it became abundantly clear that they had a good grasp of the iManage solution; their experience and expertise showed. They understood our requirement and suggested a migration approach that would be suitable for our environment.”
Ascertus has undertaken a detailed health check of the IT environment at Clarion and Roy Russell, CEO of Ascertus Limited, said, “It’s important to understand a firm’s IT infrastructure, prior to starting an implementation, as we can plan for and pre-empt issues before they turn into challenges.”
The iManage Cloud fits in well with Clarion’s outsourced IT strategy. Elaborating on the reasons for moving from an on-premises version of iManage Work to the iManage Cloud, Mitchell added, “The security delivered by the platform is unquestionable. With iManage maintaining the platform, we won’t need to worry about product updates and patches (including Microsoft), which can be resource intensive and difficult to stay on top of. We have reduced 10 servers that previously needed to be maintained, and simultaneously eliminated the cost of upskilling staff to manage this application. This move will be cost-neutral for us.”